Skip to content

Fluocinolone Acetonide

Published: July 26, 2026Updated: August 25, 2026

Yutiq is a corticosteroid intravitreal implant containing fluocinolone acetonide, designed for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. It provides sustained anti-inflammatory therapy by releasing medication directly into the eye over approximately 36 months, reducing the need for frequent injections. This implant is typically used when other treatments have not adequately controlled inflammation.

Quick summary

Yutiq is a long-acting eye implant for chronic posterior uveitis that releases corticosteroid medication over three years to control eye inflammation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

RxNorm
2099362
Generic
Yutiq
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (the back portion of the eye including the retina and choroid).

Yutiq is a corticosteroid implant that releases fluocinolone acetonide directly into the vitreous cavity over an extended period (approximately 36 months). As a corticosteroid, it suppresses inflammation by inhibiting multiple inflammatory pathways and reducing immune cell activity in the eye.

Yutiq is administered by a healthcare professional as an intravitreal injection. Common side effects include cataract formation and elevated intraocular pressure (which may require treatment or surgical intervention). There is a risk of endophthalmitis and other injection-related complications. Patients should be monitored regularly for ocular side effects. The implant is designed for single administration with sustained release and does not require removal.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy